Literature DB >> 2575732

Co-localization of adrenergic receptors and vitamin-D-dependent calcium-binding protein (calbindin) in the dopaminergic amacrine cells of the rat retina.

I Ishimoto1, H Kiyama, K Hamano, S Shiosaka, C C Malbon, M Nakauchi, P C Emson, R Manabe, M Tohyama.   

Abstract

Using antisera against tyrosine hydroxylase (TH) and purified beta 2-adrenergic receptors (beta 2-AdR), we found that TH- and AdR-like immunoreactivities coexisted in large amacrine cells. These findings indicated an association between dopamine-containing amacrine cells and adrenergic amacrine cells. The present study also showed that amacrine cells with TH-like immunoreactivity have vitamin-D-dependent calcium-binding protein (calbindin, 27,000 kDa)-like immunoreactivity as well, suggesting that calbindin plays an important postsynaptic role in dopaminergic amacrine cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575732     DOI: 10.1016/0168-0102(89)90020-5

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  4 in total

1.  Topical mydriatics affect light-evoked retinal responses in anesthetized mice.

Authors:  Deb Kumar Mojumder; Theodore G Wensel
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

Review 2.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

3.  Survival of Dopaminergic Amacrine Cells after Near-Infrared Light Treatment in MPTP-Treated Mice.

Authors:  Cassandra Peoples; Victoria E Shaw; Jonathan Stone; Glen Jeffery; Gary E Baker; John Mitrofanis
Journal:  ISRN Neurol       Date:  2012-05-30

4.  Photopic light-mediated down-regulation of local α1A-adrenergic signaling protects blood-retina barrier in experimental autoimmune uveoretinitis.

Authors:  Andrea Stofkova; Daisuke Kamimura; Takuto Ohki; Mitsutoshi Ota; Yasunobu Arima; Masaaki Murakami
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.